MCI - Innovations in the Management of Pancreatic Cancer - Evaluation

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients.	Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients. - 5	Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients. - 4	Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients. - 3	Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients. - 2	Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients. - 1
Implement approaches of selection of systemic therapies for pancreatic cancer patients.	Implement approaches of selection of systemic therapies for pancreatic cancer patients. - 5	Implement approaches of selection of systemic therapies for pancreatic cancer patients. - 4	Implement approaches of selection of systemic therapies for pancreatic cancer patients. - 3	Implement approaches of selection of systemic therapies for pancreatic cancer patients. - 2	Implement approaches of selection of systemic therapies for pancreatic cancer patients. - 1
Compare differences between local ablative therapies for patients with unresectable pancreatic cancer.	Compare differences between local ablative therapies for patients with unresectable pancreatic cancer. - 5	Compare differences between local ablative therapies for patients with unresectable pancreatic cancer. - 4	Compare differences between local ablative therapies for patients with unresectable pancreatic cancer. - 3	Compare differences between local ablative therapies for patients with unresectable pancreatic cancer. - 2	Compare differences between local ablative therapies for patients with unresectable pancreatic cancer. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

You are here

MCI - Innovations in the Management of Pancreatic Cancer - Evaluation